MARKET

PLX

PLX

Protalix Biother
AMEX
1.505
-0.215
-12.50%
Opening 14:02 05/12 EDT
OPEN
1.759
PREV CLOSE
1.720
HIGH
1.760
LOW
1.480
VOLUME
4.22M
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
0.8214
MARKET CAP
119.81M
P/E (TTM)
60.93
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PLX last week (0505-0509)?
Weekly Report · 6h ago
Protalix BioTherapeutics Reports Strong Q1 2025 Growth
TipRanks · 2d ago
Protalix BioTherapeutics Earnings Call: Growth Amid Challenges
TipRanks · 2d ago
Protalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025
Seeking Alpha · 2d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 3d ago
Protalix BioTherapeutics GAAP EPS of -$0.05 misses by $0.13, revenue of $10.11M misses by $11.49M
Seeking Alpha · 3d ago
Protalix BioTherapeutics Inc. Q1 Loss Narrows
NASDAQ · 3d ago
Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results
PR Newswire · 3d ago
More
About PLX
More
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of uncontrolled gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase) - a chemically modified enzyme to treat uncontrolled gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate. Its product includes Elelyso and Elfabrio. Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease.
Recently
Symbol
Price
%Change
    PLX
  • 1.505
  • -12.50%

Webull offers Protalix Biotherapeutics Inc stock information, including AMEX: PLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLX stock methods without spending real money on the virtual paper trading platform.